The **Alpha-Fetoprotein (AFP) Diagnostic Test** is a crucial blood screening tool primarily used to measure the levels of AFP, a protein produced mainly by the fetal liver and yolk sac. In pregnant individuals, elevated or abnormally low maternal serum AFP levels can indicate potential fetal neural tube defects, like spina bifida, or chromosomal abnormalities.

For adults, the AFP test serves as an essential tumor marker. Significantly elevated levels are strongly associated with liver cancer (hepatocellular carcinoma) and certain germ cell tumors of the ovaries or testes, aiding clinicians in cancer diagnosis, staging, and monitoring treatment efficacy.

The **Alpha Thalassemia Gene Analysis Diagnostic Test** is a specialized molecular blood test used to detect deletions or mutations in the alpha-globin genes ($HBA1$ and $HBA2$). Since alpha thalassemia is an inherited blood disorder that reduces hemoglobin production, this genetic analysis is the definitive method for identifying carriers and diagnosing varying severities of the condition, from silent carriers to HbH disease.

This test is highly critical for prenatal screening, preconception counseling, and evaluating individuals with unexplained microcytic anemia. By precisely mapping genetic variations, it allows clinicians to predict clinical outcomes and guide personalized management strategies.

Alpha wellness 1.3 package consists of following blood tests:
Testosterone, Iron studies (Iron, TIBC, Transferrin saturation), Liver Function Test, Lipid Profile, Thyroid Profile, Hba1c, Kidney Profile, GD Wellness Vitamin profile, CBC, ESR, C-Reactive Protein.